Regulatory Q&A Forum
Ask questions, share knowledge, and get help from the regulatory community
I'm a cosmetics manufacturer based outside the EU. I've heard about Responsible Person requirements under EU Cosmetics Regulation but I'm not sure if they apply to my situation. Can you explain what a...
I'm a medical device manufacturer based outside the UK. I've heard about UK RP requirements under UK MDR 2002 but I'm not sure if they apply to my situation. Can you explain what a UK Responsible Pers...
I'm a medical device manufacturer based outside the EU. I've heard about EC REP requirements under EU MDR/IVDR but I'm not sure if they apply to my situation. Can you explain what an EU Authorized Rep...
I'm a medical device manufacturer looking to enter the Swiss market. I've heard about CH-REP requirements but I'm not sure if they apply to my situation. Can you explain what a Swiss Authorized Repres...
When developing a novel Class II in-vitro diagnostic (IVD), what is the strategic framework for determining if it falls under an existing classification regulation, thereby allowing a 510(k) pathway, ...
When a non-EU medical device manufacturer plans to enter the European market, they must appoint an EU Authorized Representative (AR) to comply with the Medical Device Regulation (MDR). However, other ...
The Modernization of Cosmetics Regulation Act (MoCRA) mandates that foreign cosmetic facilities designate a U.S. Agent as a prerequisite for FDA registration. While this is a clear requirement, what d...
With the EU Medical Device Regulation (MDR) establishing the critical role of the Person Responsible for Regulatory Compliance (PRRC), many manufacturers—particularly small and medium-sized enterprise...
For a company developing a novel Software as a Medical Device (SaMD) intended for both diagnostic screening and pharmacogenetic assessment, what are the key considerations for determining the appropri...
With the Carbon Border Adjustment Mechanism (CBAM) transitional period underway and full implementation approaching, non-EU operators in affected sectors must appoint an authorized representative to m...
With the implementation of the Modernization of Cosmetics Regulation Act (MoCRA), foreign cosmetic facilities are now required to designate a U.S. Agent to serve as the primary point of communication ...
Given the critical role of the Person Responsible for Regulatory Compliance (PRRC) under the EU MDR, and with regulatory bodies issuing updated guidance on Post-Market Surveillance and Vigilance (PMSV...
When a non-EU manufacturer plans for the upcoming REACH registration deadlines, such as the one in 2026, a key budgetary question is the cost of securing an Only Representative (OR). However, a simple...
Given the significant French VAT reforms anticipated for 2026, including the end of customs procedure 42 which will mandate a fiscal representative for many non-EU businesses, what comprehensive frame...
For foreign medical device manufacturers preparing for the transition to the Quality Management System Regulation (QMSR), selecting a U.S. Agent involves more than just fulfilling a basic registration...
For foreign medical device manufacturers preparing for the transition from the Quality System Regulation (QSR) to the new Quality Management System Regulation (QMSR), the role of a U.S. Agent can exte...
Foreign medical device manufacturers preparing for the Quality Management System Regulation (QMSR) compliance deadline often look to their U.S. Agent for transition support. While the basic responsibi...
How can a medical device manufacturer effectively evaluate an outsourced 'Person Responsible for Regulatory Compliance' (PRRC) service to ensure it can manage evolving Post-Market Surveillance and Vig...
With ongoing developments in European regulations, including potential updates to Post-Market Surveillance and Vigilance (PMSV) reporting, how can a medical device manufacturer effectively evaluate a ...
For a non-EU manufacturer of a medical device, such as a dental handpiece and its accessories governed by regulations like 21 CFR 872.4200, navigating international compliance presents significant cha...